| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |